PharmaVentures acts as exclusive M&A advisor to the PE firm capiton AG on the successful sale of MiP Pharma's Sterile Production Facility to FAMAR Group

PharmaVentures Ltd United Kingdom

(in and out licensing)Strategy (pricing and market access, commercial due diligence, valuations)Valuations (licensing, M&A, and fundraising)Pricing and Market Access

PharmaVentures is based in London, UK, and employs over 30 professionals and has associates in Europe and Asia-Pacific.

NOTE: This Press release is issued by PharmaVentures Limited, whose wholly owned subsidiary PharmaVentures Capital Limited is authorised and regulated by the Financial Conduct Authority (741356). This communication is for information purposes only and does not constitute an offer or solicitation to purchase or engage in any investment products, securities or services and should not be deemed as such.

For more details, visit https://www.pharmaventures.com

Follow us on LinkedIn: https://www.linkedin.com/company/pharmaventures/

Photo - https://mma.prnewswire.com/media/2703311/PharmaVentures.jpg
Logo - https://mma.prnewswire.com/media/2703310/PV_Logo.jpg

 

 

View original content:https://www.prnewswire.co.uk/news-releases/pharmaventures-acts-as-exclusive-ma-advisor-to-the-pe-firm-capiton-ag-on-the-successful-sale-of-mip-pharmas-sterile-production-facility-to-famar-group-302473613.html